Giovanni Monteleone & Carmine Stolfi. (2022). Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. MDPI AG.
Chicago Style (17th ed.) CitationGiovanni Monteleone and Carmine Stolfi. Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. MDPI AG, 2022.
MLA (9th ed.) CitationGiovanni Monteleone and Carmine Stolfi. Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.